Loss of BMP7 in glioblastoma, breast, and prostate cancers, therefore, predisposes to enhanced EMT and acquisition of invasive/metastatic traits suggesting a protective role for BMP7 in cancer progression. The gene discussed is BMP7; the disease is glioblastoma.